GOLDMAN SACHS GROUP INC - RECRO PHARMA INC ownership

RECRO PHARMA INC's ticker is REPH and the CUSIP is 75629F109. A total of 48 filers reported holding RECRO PHARMA INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of RECRO PHARMA INC
ValueSharesWeighting
Q2 2023$49,743
-1.9%
45,221
+6.1%
0.00%
Q1 2023$50,714
-26.0%
42,617
-7.3%
0.00%
Q4 2022$68,515
+197.9%
45,983
+257.9%
0.00%
Q1 2022$23,000
+27.8%
12,847
+19.7%
0.00%
Q4 2021$18,000
-81.4%
10,730
-77.1%
0.00%
Q3 2021$97,000
-11.0%
46,895
-0.4%
0.00%
Q2 2021$109,000
+202.8%
47,078
+260.4%
0.00%
Q1 2021$36,000
-28.0%
13,064
-24.8%
0.00%
Q4 2020$50,000
-84.8%
17,372
-88.9%
0.00%
Q3 2020$330,000
-0.9%
157,066
+114.9%
0.00%
Q2 2020$333,000
-41.4%
73,093
+5.1%
0.00%
Q1 2020$568,000
-10.4%
69,526
+101.3%
0.00%
Q4 2019$634,000
-3.9%
34,542
-42.0%
0.00%
Q3 2019$660,000
-35.4%
59,558
-40.8%
0.00%
Q2 2019$1,022,000
+176.2%
100,573
+59.3%
0.00%
Q1 2019$370,000
+2.2%
63,148
+23.9%
0.00%
Q4 2018$362,000
+306.7%
50,975
+305.1%
0.00%
Q3 2018$89,000
-84.1%
12,582
-75.2%
0.00%
Q1 2018$559,000
+9.8%
50,793
-10.4%
0.00%
Q3 2017$509,000
+20.0%
56,658
-6.0%
0.00%
Q2 2017$424,000
+282.0%
60,276
+373.9%
0.00%
Q1 2017$111,000
-61.7%
12,719
-64.7%
0.00%
Q4 2016$290,00036,0410.00%
Other shareholders
RECRO PHARMA INC shareholders Q3 2023
NameSharesValueWeighting ↓
Athyrium Capital Management, LP 2,202,420$6,145,0003.11%
Samjo Capital LLC 560,000$1,562,0001.16%
MAK CAPITAL ONE LLC 1,224,264$3,416,0000.81%
Cowen Prime Services LLC 470,500$1,313,0000.50%
Portolan Capital Management 1,957,283$5,461,0000.43%
Parkman Healthcare Partners LLC 601,967$1,679,0000.39%
Rubric Capital Management LP 1,076,587$3,004,0000.18%
Frontier Wealth Management LLC 49,112$2,142,0000.16%
ESSEX INVESTMENT MANAGEMENT CO LLC 466,992$1,303,0000.16%
AWM Investment Company, Inc. 391,304$1,092,0000.12%
View complete list of RECRO PHARMA INC shareholders